Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Matsukiyococokara & Co. (3088:JPX), powered by AI.
Matsukiyococokara & Co. is currently trading at ¥2,337. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Matsukiyococokara & Co. on Alpha Lenz.
Matsukiyococokara & Co.'s P/E ratio is 17.5.
“Matsukiyococokara & Co. trades at a P/E of 17.5 (fair value) with solid ROE of 10.6%. 3Y revenue CAGR of 13.3% highlights clear growth momentum.”
Ask for details →Matsukiyococokara & Co. is a prominent entity within the retail sector, operating as a major drugstore chain in Japan. This asset primarily serves the consumer market through its extensive network of stores, providing a wide range of health-related products, cosmetics, daily necessities, and over-the-counter pharmaceuticals. The company aims to meet consumer needs by offering both Japanese and international brands, alongside its private-label products. Matsukiyococokara & Co. has a strong presence in the densely populated urban areas and continues to expand its reach across the country. The company caters to diverse customer demographics, offering accessible and convenient shopping experiences. Its strategic focus includes enhancing digital sales channels and utilizing data-driven approaches to personalize services and improve customer experience. In the financial market, the company is noteworthy for investors and analysts interested in the retail and healthcare sectors, reflecting broader market trends and consumer behaviors. As a player in the competitive Japanese retail landscape, Matsukiyococokara & Co. contributes significantly to the accessibility of health and beauty products, influencing both domestic consumption patterns and the health and wellness industry.
“Matsukiyococokara & Co. trades at a P/E of 17.5 (fair value) with solid ROE of 10.6%. 3Y revenue CAGR of 13.3% highlights clear growth momentum.”
Ask for details →Matsukiyococokara & Co. (ticker: 3088) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers). It has approximately 12,753 employees. Market cap is $954.6B.
The current price is 2,337 with a P/E ratio of 17.46x and P/B of 1.83x.
ROE is 10.56% and operating margin is 7.73%. Annual revenue is $1.1T.